Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

GBD 2013 Risk Collaborators

doi:10.1016/S0140-6736(15)00128-2

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

GBD 2013 Risk Collaborators

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2287-2323
Number of pages	37
Journal	The Lancet
Volume	386
Issue number	10010
DOIs	https://doi.org/10.1016/S0140-6736(15)00128-2
Publication status	Published - 5 Dec 2015
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(15)00128-2

Cite this

@article{fd939e9ef7454b59906d4d4b3c324beb,

title = "Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013",

author = "{GBD 2013 Risk Collaborators} and Forouzanfar, {M. H.} and L. Alexander and Bachman, {V. F.} and S. Biryukov and M. Brauer and D. Casey and Coates, {M. M.} and K. Delwiche and K. Estep and Frostad, {J. J.} and Astha, {K. C.} and Kyu, {H. H.} and M. Moradi-Lakeh and M. Ng and Thomas, {B. A.} and C. Atkinson and Lim, {S. S.} and Wright, {J. L.} and Shin, {H. H.} and S. Alam and Ali, {M. K.} and Y. Liu and N. Lopez and A. Basu and Huang, {J. J.} and Nguyen, {N. T.} and J. Wang and Williams, {T. N.} and W. Chen and C. Cooper and J. Leigh and Y. Li and S. Liu and L. Wang and Y. Zheng and C. Huang and Phillips, {M. R.} and Kemp, {A. H.} and J. Lee and M. Levi and Y. Wang and Moore, {A. R.} and Perry, {S. A.L.} and S. Saha and Saunders, {J. E.} and G. Shaddick and A. Singh and W. Wang and C. Yu and Y. Zhao",

note = "Funding Information: RA-C has been employed by GSK, activities not related to this manuscript. JP is supported by a career development fellowship from the Wellcome Trust, Public Health Foundation of India, and a consortium of UK Universities. CK receives research grants from Brazilian public funding agencies Conselho Nacional de Desenvolvimento Cient{\'i}fico e Tecnol{\'o}gico (CNPq), Coordena{\c c}{\~a}o de Aperfei{\c c}oamento de Pessoal de N{\'i}vel Superior (CAPES), and Funda{\c c}{\~a}o de Amparo {\`a} Pesquisa do Estado do Rio Grande do Sul (FAPERGS). He has also received authorship royalties from publishers Artmed and Manole. RSP Jr has been medical director for United Laboratories Consumer Health Division—United Laboratories Inc. GVP is employed by University of Sao Paulo and receives research support from the National Council for Scientific and Technological Development (CNPq), the S{\~a}o Paulo Research Foundation (FAPESP), Grand Challenges Canada, Fundacao Maria Cecilia Souto Vidigal, and the University of Sao Paulo. He has served as a consultant and speaker to Shire and has received royalties from Manole Editors. HJL, in addition to grant funding from the Bill & Melinda Gates Foundation, EU, WHO and Novartis, has done some consulting for GSK and on the Merck Vaccines Global Strategic Advisory Boardm outside of this report. All other authors declare no competing interests. Funding Information: We thank the countless individuals who have contributed to the Global Burden of Disease Study 2013 in various capacities. We acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank James Bullard, Serkan Yalcin, Evan Laurie, Andrew Ernst, Elizabeth Roberts, and Peter Speyer for their tireless support of the computational infrastructure required to produce the results and production of visualisations to review the results; Abigail McLain for her guidance on organising data; Caitlyn Steiner for her management of the GBD estimation; Adrienne Chew for her editorial assistance; Kelsey Pierce for her valuable guidance; and Linda A Ettinger for her expert executive support. We would also like to thank Ivan Ivanov for his contributions. The following individuals acknowledge various forms of institutional support: HC is supported by the Intramural Program of the NIH, the National Institute of Environmental Health Science; KD is supported by a Wellcome Trust Research Training Fellowship ( grant number 099876 )]; KBG received the NHMRC-Gustav Nossal scholarship sponsored by CSL 2015 (his award is peer-reviewed through the standard NHMRC peer-review process; CSL played no part in selection of the awardee); HH's contribution of this effort was partially supported by NIH ROI ES021446 ; NK received funding from the Japan Society for the Promotion of Science (JSPS) KAKENHI ( grant number 25253045 ); YK would like to thank the National Heart Foundation of Australia for its financial support for work on modelling cardiovascular disease and risk factors at the University of Canberra; SJL is supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; KM reports personal fees from Mitsubishi Tanabe Pharma, Kyowa Hakko Kirin, and MSD outside the submitted work; WM is program analyst at the UNFPA country office in Peru, which does not necessarily endorse the study; FC-L is partially supported by the PROMETEOII 2015 program/Conselleria d'Educaci{\'o}, Investigaci{\'o}, Cultura i Esport, Generalitat Valenciana and the CIBERSAM/Institute of Health Carlos III, Spanish Ministry of Science and Innovation; DM reports ad-hoc honoraria or consulting from Bunge, Haas Avocado Board, Nutrition Impact, Amarin, Astra Zeneca, Boston Heart Diagnostics, and Life Sciences Research Organization; and is on the scientific advisory board for Unilever North America; UM gratefully acknowledges funding from the German National Cohort Consortium; CDP, in the past 3 years has received consultancy payments from Pfizer and from Nutricia; DAQ was supported by The Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award number 5T32HD057822; KR was funded by the UK NIHR Oxford BRC and NIHR CDF; IR is required to include the following statement: The authors alone are responsible for the views expressed in this Article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated; JR received additional funding from the WHO for the work on alcohol as a risk factor; SS received a research support grant from NIH and the National Research Foundation and has received pharmaceutical sponsorship from Pfizer, AstraZeneca, Servier, and Dr Reddy's, speakers honoraria from Pfizer and Lundbeck, and honoraria from the Discovery Foundation and Cambridge University Press; DJS, in the past 3 years, has received research grants and/or consultancy honoraria from AMBRF, Biocodex, Cipla, Lundbeck, National Responsible Gambling Foundation, Novartis, Servier, and Sun; AGT acknowledges a senior research fellowship from the National Health & Medical Research Council (Australia; 1042600); and GDT was supported by a Center Grant from the National Institutes of Environmental Health Sciences (ES00260). ",

year = "2015",

month = dec,

day = "5",

doi = "10.1016/S0140-6736(15)00128-2",

language = "English",

volume = "386",

pages = "2287--2323",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10010",

}

GBD 2013 Risk Collaborators 2015, 'Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013', The Lancet, vol. 386, no. 10010, pp. 2287-2323. https://doi.org/10.1016/S0140-6736(15)00128-2

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. / GBD 2013 Risk Collaborators.
In: The Lancet, Vol. 386, No. 10010, 05.12.2015, p. 2287-2323.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013

T2 - A systematic analysis for the Global Burden of Disease Study 2013

AU - GBD 2013 Risk Collaborators

AU - Forouzanfar, M. H.

AU - Alexander, L.

AU - Bachman, V. F.

AU - Biryukov, S.

AU - Brauer, M.

AU - Casey, D.

AU - Coates, M. M.

AU - Delwiche, K.

AU - Estep, K.

AU - Frostad, J. J.

AU - Astha, K. C.

AU - Kyu, H. H.

AU - Moradi-Lakeh, M.

AU - Ng, M.

AU - Thomas, B. A.

AU - Atkinson, C.

AU - Lim, S. S.

AU - Wright, J. L.

AU - Shin, H. H.

AU - Alam, S.

AU - Ali, M. K.

AU - Liu, Y.

AU - Lopez, N.

AU - Basu, A.

AU - Huang, J. J.

AU - Nguyen, N. T.

AU - Wang, J.

AU - Williams, T. N.

AU - Chen, W.

AU - Cooper, C.

AU - Leigh, J.

AU - Li, Y.

AU - Liu, S.

AU - Wang, L.

AU - Zheng, Y.

AU - Huang, C.

AU - Phillips, M. R.

AU - Kemp, A. H.

AU - Lee, J.

AU - Levi, M.

AU - Wang, Y.

AU - Moore, A. R.

AU - Perry, S. A.L.

AU - Saha, S.

AU - Saunders, J. E.

AU - Shaddick, G.

AU - Singh, A.

AU - Wang, W.

AU - Yu, C.

AU - Zhao, Y.

N1 - Funding Information: RA-C has been employed by GSK, activities not related to this manuscript. JP is supported by a career development fellowship from the Wellcome Trust, Public Health Foundation of India, and a consortium of UK Universities. CK receives research grants from Brazilian public funding agencies Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS). He has also received authorship royalties from publishers Artmed and Manole. RSP Jr has been medical director for United Laboratories Consumer Health Division—United Laboratories Inc. GVP is employed by University of Sao Paulo and receives research support from the National Council for Scientific and Technological Development (CNPq), the São Paulo Research Foundation (FAPESP), Grand Challenges Canada, Fundacao Maria Cecilia Souto Vidigal, and the University of Sao Paulo. He has served as a consultant and speaker to Shire and has received royalties from Manole Editors. HJL, in addition to grant funding from the Bill & Melinda Gates Foundation, EU, WHO and Novartis, has done some consulting for GSK and on the Merck Vaccines Global Strategic Advisory Boardm outside of this report. All other authors declare no competing interests. Funding Information: We thank the countless individuals who have contributed to the Global Burden of Disease Study 2013 in various capacities. We acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank James Bullard, Serkan Yalcin, Evan Laurie, Andrew Ernst, Elizabeth Roberts, and Peter Speyer for their tireless support of the computational infrastructure required to produce the results and production of visualisations to review the results; Abigail McLain for her guidance on organising data; Caitlyn Steiner for her management of the GBD estimation; Adrienne Chew for her editorial assistance; Kelsey Pierce for her valuable guidance; and Linda A Ettinger for her expert executive support. We would also like to thank Ivan Ivanov for his contributions. The following individuals acknowledge various forms of institutional support: HC is supported by the Intramural Program of the NIH, the National Institute of Environmental Health Science; KD is supported by a Wellcome Trust Research Training Fellowship ( grant number 099876 )]; KBG received the NHMRC-Gustav Nossal scholarship sponsored by CSL 2015 (his award is peer-reviewed through the standard NHMRC peer-review process; CSL played no part in selection of the awardee); HH's contribution of this effort was partially supported by NIH ROI ES021446 ; NK received funding from the Japan Society for the Promotion of Science (JSPS) KAKENHI ( grant number 25253045 ); YK would like to thank the National Heart Foundation of Australia for its financial support for work on modelling cardiovascular disease and risk factors at the University of Canberra; SJL is supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; KM reports personal fees from Mitsubishi Tanabe Pharma, Kyowa Hakko Kirin, and MSD outside the submitted work; WM is program analyst at the UNFPA country office in Peru, which does not necessarily endorse the study; FC-L is partially supported by the PROMETEOII 2015 program/Conselleria d'Educació, Investigació, Cultura i Esport, Generalitat Valenciana and the CIBERSAM/Institute of Health Carlos III, Spanish Ministry of Science and Innovation; DM reports ad-hoc honoraria or consulting from Bunge, Haas Avocado Board, Nutrition Impact, Amarin, Astra Zeneca, Boston Heart Diagnostics, and Life Sciences Research Organization; and is on the scientific advisory board for Unilever North America; UM gratefully acknowledges funding from the German National Cohort Consortium; CDP, in the past 3 years has received consultancy payments from Pfizer and from Nutricia; DAQ was supported by The Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award number 5T32HD057822; KR was funded by the UK NIHR Oxford BRC and NIHR CDF; IR is required to include the following statement: The authors alone are responsible for the views expressed in this Article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated; JR received additional funding from the WHO for the work on alcohol as a risk factor; SS received a research support grant from NIH and the National Research Foundation and has received pharmaceutical sponsorship from Pfizer, AstraZeneca, Servier, and Dr Reddy's, speakers honoraria from Pfizer and Lundbeck, and honoraria from the Discovery Foundation and Cambridge University Press; DJS, in the past 3 years, has received research grants and/or consultancy honoraria from AMBRF, Biocodex, Cipla, Lundbeck, National Responsible Gambling Foundation, Novartis, Servier, and Sun; AGT acknowledges a senior research fellowship from the National Health & Medical Research Council (Australia; 1042600); and GDT was supported by a Center Grant from the National Institutes of Environmental Health Sciences (ES00260).

PY - 2015/12/5

Y1 - 2015/12/5

UR - http://www.scopus.com/inward/record.url?scp=85049491557&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(15)00128-2

DO - 10.1016/S0140-6736(15)00128-2

M3 - Article

C2 - 26364544

AN - SCOPUS:85049491557

SN - 0140-6736

VL - 386

SP - 2287

EP - 2323

JO - The Lancet

JF - The Lancet

IS - 10010

ER -

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

UN SDGs

Access to Document

Other files and links

Cite this